These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22800462)

  • 21. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
    Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
    Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic glycopeptides for the development of cancer vaccines.
    Liakatos A; Kunz H
    Curr Opin Mol Ther; 2007 Feb; 9(1):35-44. PubMed ID: 17330400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines.
    Chua BY; Zeng W; Jackson DC
    Methods Mol Biol; 2008; 494():247-61. PubMed ID: 18726578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fully synthetic immunogen carrying a carcinoma-associated carbohydrate for active specific immunotherapy.
    Lo-Man R; Bay S; Vichier-Guerre S; Dériaud E; Cantacuzène D; Leclerc C
    Cancer Res; 1999 Apr; 59(7):1520-4. PubMed ID: 10197623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
    Lo-Man R; Vichier-Guerre S; Bay S; Dériaud E; Cantacuzène D; Leclerc C
    J Immunol; 2001 Feb; 166(4):2849-54. PubMed ID: 11160353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes.
    Sarkar S; Salyer AC; Wall KA; Sucheck SJ
    Bioconjug Chem; 2013 Mar; 24(3):363-75. PubMed ID: 23444835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and immunological evaluation of an antitumor neoglycopeptide vaccine bearing a novel homoserine Tn antigen.
    Vichier-Guerre S; Lo-Man R; Huteau V; Dériaud E; Leclerc C; Bay S
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3567-70. PubMed ID: 15177475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine Candidates.
    Chang TC; Manabe Y; Fujimoto Y; Ohshima S; Kametani Y; Kabayama K; Nimura Y; Lin CC; Fukase K
    Angew Chem Int Ed Engl; 2018 Jul; 57(27):8219-8224. PubMed ID: 29768704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.
    Sungsuwan S; Yin Z; Huang X
    ACS Appl Mater Interfaces; 2015 Aug; 7(31):17535-44. PubMed ID: 26200668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tn antigen analogues: the synthetic way to "upgrade" an attracting tumour associated carbohydrate antigen (TACA).
    Nativi C; Papi F; Roelens S
    Chem Commun (Camb); 2019 Jul; 55(54):7729-7736. PubMed ID: 31225574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new model for the presentation of tumor-associated antigens and the quest for an anticancer vaccine: a solution to the synthesis challenge via ring-closing metathesis.
    Jeon I; Lee D; Krauss IJ; Danishefsky SJ
    J Am Chem Soc; 2009 Oct; 131(40):14337-44. PubMed ID: 19746915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calix[4]arene decorated with four Tn antigen glycomimetic units and P3CS immunoadjuvant: synthesis, characterization, and anticancer immunological evaluation.
    Geraci C; Consoli GM; Galante E; Bousquet E; Pappalardo M; Spadaro A
    Bioconjug Chem; 2008 Mar; 19(3):751-8. PubMed ID: 18293897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating strategies to enhance the anti-tumor immune response to a carbohydrate mimetic peptide vaccine.
    Monzavi-Karbassi B; Pashov A; Jousheghany F; Artaud C; Kieber-Emmons T
    Int J Mol Med; 2006 Jun; 17(6):1045-52. PubMed ID: 16685414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunological response from an entirely carbohydrate antigen: design of synthetic vaccines based on Tn-PS A1 conjugates.
    De Silva RA; Wang Q; Chidley T; Appulage DK; Andreana PR
    J Am Chem Soc; 2009 Jul; 131(28):9622-3. PubMed ID: 19552408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic multivalent glycopeptide-lipopeptide antitumor vaccines: impact of the cluster effect on the killing of tumor cells.
    Cai H; Sun ZY; Chen MS; Zhao YF; Kunz H; Li YM
    Angew Chem Int Ed Engl; 2014 Feb; 53(6):1699-703. PubMed ID: 24449389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fully synthetic four-component antitumor vaccine consisting of a mucin glycopeptide antigen combined with three different T-helper-cell epitopes.
    Palitzsch B; Hartmann S; Stergiou N; Glaffig M; Schmitt E; Kunz H
    Angew Chem Int Ed Engl; 2014 Dec; 53(51):14245-9. PubMed ID: 25318465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design and immunogenicity of liposome-based diepitope constructs: application to synthetic oligosaccharides mimicking the Shigella flexneri 2a O-antigen.
    Said Hassane F; Phalipon A; Tanguy M; Guerreiro C; Bélot F; Frisch B; Mulard LA; Schuber F
    Vaccine; 2009 Aug; 27(39):5419-26. PubMed ID: 19559116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterovalent Glycodendrimers as Epitope Carriers for Antitumor Synthetic Vaccines.
    Pifferi C; Thomas B; Goyard D; Berthet N; Renaudet O
    Chemistry; 2017 Nov; 23(64):16283-16296. PubMed ID: 28845889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 2 agonist Pam3CSK4 enhances the induction of antigen-specific tolerance via the sublingual route.
    Lombardi V; Van Overtvelt L; Horiot S; Moussu H; Chabre H; Louise A; Balazuc AM; Mascarell L; Moingeon P
    Clin Exp Allergy; 2008 Nov; 38(11):1819-29. PubMed ID: 18644025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of selected LeY and KH-1 analogues: a medicinal chemistry approach to vaccine optimization.
    Spassova MK; Bornmann WG; Ragupathi G; Sukenick G; Livingston PO; Danishefsky SJ
    J Org Chem; 2005 Apr; 70(9):3383-95. PubMed ID: 15844973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.